Annual Review of Biomedical Engineering

Annual Review of Biomedical Engineering
source
Title	Annual Review of Biomedical Engineering
Discipline	Biomedical engineering
Abbreviation	Annu. Rev. Biomed. Eng.
Editor	Robert Langer
Publisher	Annual Reviews
Country	United States
History	1999–present
Frequency	Annual
Issn	1523-9829

Contents

Annual Review of Biomedical Engineering is an annual peer-reviewed journal that synthesizes advances at the intersection of Robert S. Langer-style translational research, National Institutes of Health-funded programs, and industrial innovation exemplified by firms like Medtronic, Stryker Corporation, and Johnson & Johnson. It serves as a bridge between laboratory discoveries at institutions such as Massachusetts Institute of Technology, Stanford University, Harvard University, California Institute of Technology, and clinical translation in settings linked to Mayo Clinic, Cleveland Clinic, and Johns Hopkins Hospital.

History

The journal was established in 1999 by Annual Reviews to capture cross-cutting developments connecting investigators from Brown University, Duke University, University of California, Berkeley, Imperial College London, and ETH Zurich. Early editorial leadership included figures associated with National Science Foundation initiatives and collaborators from Wellcome Trust-funded networks, reflecting ties to program directors at European Molecular Biology Laboratory and advisory boards drawn from American Institute for Medical and Biological Engineering fellows. Its founding responded to convergent agendas set by symposia at venues like Gordon Research Conferences, workshops hosted by Howard Hughes Medical Institute, and NATO science panels.

The journal emphasizes comprehensive reviews that integrate breakthroughs in biomaterials pioneered by researchers at Wyss Institute, device innovations from companies such as Boston Scientific and GE Healthcare, and computational modeling advanced at Los Alamos National Laboratory, Argonne National Laboratory, and Lawrence Berkeley National Laboratory. Topic areas span tissue engineering with links to work at Salk Institute and Karolinska Institutet, medical imaging developments tied to Siemens Healthineers collaborations, regenerative medicine research intersecting with Cell Therapy programs, and biomechanics studies associated with American Society of Mechanical Engineers conferences. Articles synthesize primary literature from labs led by awardees of the National Medal of Technology and Innovation, Breakthrough Prize, and Japan Prize.

The editorial committee, drawn from elected fellows of Royal Society and members of National Academy of Engineering, commissions authoritative authors with track records at institutions such as Yale University, University of Pennsylvania, Columbia University, and University of Cambridge. Submitted manuscripts undergo peer review by reviewers affiliated with centers like Fred Hutchinson Cancer Research Center, Scripps Research, Vanderbilt University Medical Center, and regulatory scientists from U.S. Food and Drug Administration. The process reflects standards endorsed by organizations including Committee on Publication Ethics and follows practices similar to editorial boards of Nature Biomedical Engineering and Science Translational Medicine.

Published annually by Annual Reviews in the United States, the journal is distributed to libraries at universities such as University of Oxford, Princeton University, University of Tokyo, and research institutes like Max Planck Society departments. Access models have evolved alongside mandates from funders including Wellcome Trust, European Research Council, and Howard Hughes Medical Institute, influencing hybrid open access arrangements and subscription practices comparable to titles from Elsevier and Springer Nature. Print and electronic editions are catalogued in bibliographic services such as PubMed, Scopus, and Web of Science.

The journal is cited in policy reports by agencies such as Centers for Disease Control and Prevention and in white papers from foundations like Gates Foundation and Rockefeller Foundation. Its reviews inform standards bodies including International Organization for Standardization committees and contribute to consensus statements produced by American Heart Association and World Health Organization. Citation metrics place it prominently among review journals read by leaders at Genentech, Amgen, Pfizer, and academic centers that compete for grants from National Cancer Institute and National Institute of Biomedical Imaging and Bioengineering.

Contributors have included prizewinning investigators affiliated with University of California, San Francisco, Northwestern University, University of Michigan, Texas A&M University, and Monash University. Notable reviews have synthesized work on biomaterial scaffolds by scholars connected to Shinya Yamanaka-adjacent pluripotency research, immunoengineering contributions aligned with James P. Allison-style checkpoint blockade studies, and neural interface overviews relevant to projects at Neuralink and laboratories collaborating with Defense Advanced Research Projects Agency. Influential articles often cross-reference clinical trials registered at ClinicalTrials.gov and landmark studies published in outlets like The Lancet, The New England Journal of Medicine, and Nature Medicine.

Category:Biomedical engineering journals